| Ident. | Authors (with country if any) | Title |
|---|
| 000074 (2020) |
Md Tanvir Kabir [Bangladesh] ; Md Sahab Uddin [Bangladesh] ; Md Farhad Hossain [Bangladesh, Corée du Sud] ; Jawaher A. Abdulhakim [Arabie saoudite] ; Md Asraful Alam [République populaire de Chine] ; Ghulam Md Ashraf [Arabie saoudite] ; Simona G. Bungau [Roumanie] ; May N. Bin-Jumah [Arabie saoudite] ; Mohamed M. Abdel-Daim [Arabie saoudite, Égypte] ; Lotfi Aleya [France] | nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. |
| 000085 (2020) |
I A Gundarov [Russie] | [The patterns of seasonal outbreaks of acute respiratory diseases]. |
| 000376 (2020) |
Victor Altmayer [France] ; Samir Saheb [France] ; Benjamin Rohaut [France] ; Clémence Marois [France] ; Albert Cao [France] ; Antonio Gallo [France] ; Loïc Le Guennec [France] ; Nicolas Weiss [France] ; Sophie Demeret [France] | Therapeutic plasma exchange in a critically ill Covid-19 patient. |
| 000734 (2020) |
Alexis Mathian [France] ; Marc Pineton De Chambrun [France] ; Alain Combes [France] ; Zahir Amoura [France] | Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al. |
| 000748 (2020) |
M. Pineton De Chambrun [France] ; C. Frere [France] ; M. Miyara [France] ; Z. Amoura [France] ; I. Martin-Toutain [France] ; A. Mathian [France] ; G. Hekimian [France] ; A. Combes [France] | Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?"'. |
| 000813 (2020) |
Laurent Dortet ; Cecile Emeraud ; Christelle Vauloup-Fellous [France] ; Mouna Khecharem ; Jean-Baptiste Ronat [France] ; Nicolas Fortineau ; Anne-Marie Roque-Afonso [France] ; Thierry Naas | Rapid Determination of SARS-CoV-2 Antibodies Using a Bedside, Point-of-Care, Serological Test. |
| 000849 (2020) |
Katharine H D. Crawford [États-Unis] ; Rachel Eguia [États-Unis] ; Adam S. Dingens [États-Unis] ; Andrea N. Loes [États-Unis] ; Keara D. Malone [États-Unis] ; Caitlin R. Wolf [États-Unis] ; Helen Y. Chu [États-Unis] ; M Alejandra Tortorici [États-Unis, France] ; David Veesler [États-Unis] ; Michael Murphy [États-Unis] ; Deleah Pettie [États-Unis] ; Neil P. King [États-Unis] ; Alejandro B. Balazs [États-Unis] ; Jesse D. Bloom [États-Unis] | Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. |
| 000962 (2020) |
Charlotte Charpentier [France] ; Houria Ichou [France] ; Florence Damond [France] ; Elisabeth Bouvet [France] ; Marie-Laure Chaix [France] ; Valentine Ferré [France] ; Constance Delaugerre [France] ; Nadia Mahjoub [France] ; Lucile Larrouy [France] ; Quentin Le Hingrat [France] ; Benoit Visseaux [France] ; Vincent Mackiewicz [France] ; Diane Descamps [France] ; Nadhira Fidouh-Houhou [France] | Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott). |
| 000A41 (2020) |
Asmaa Hachim [République populaire de Chine] ; Niloufar Kavian [République populaire de Chine, France] ; Carolyn A. Cohen [République populaire de Chine] ; Alex W H. Chin [République populaire de Chine] ; Daniel K W. Chu [République populaire de Chine] ; Chris K P. Mok [République populaire de Chine] ; Owen T Y. Tsang [République populaire de Chine] ; Yiu Cheong Yeung [République populaire de Chine] ; Ranawaka A P M. Perera [République populaire de Chine] ; Leo L M. Poon [République populaire de Chine] ; J S Malik Peiris [République populaire de Chine] ; Sophie A. Valkenburg [République populaire de Chine] | ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. |
| 000A88 (2020) |
Ahidjo Ayouba [France] ; Guillaume Thaurignac [France] ; David Morquin [France] ; Edouard Tuaillon [France] ; Raisa Raulino [France] ; Antoine Nkuba [France] ; Audrey Lacroix [France] ; Nicole Vidal [France] ; Vincent Foulongne [France] ; Vincent Le Moing [France] ; Jacques Reynes [France] ; Eric Delaporte [France] ; Martine Peeters [France] | Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV. |
| 000B64 (2020) |
Inès Harzallah [France] ; Agathe Debliquis [France] ; Bernard Drénou [France] | Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply. |
| 000B71 (2020) |
Pierre Gallian [France] ; Boris Pastorino [France] ; Pascal Morel [France] ; Jacques Chiaroni [France] ; Laetitia Ninove [France] ; Xavier De Lamballerie [France] | Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. |
| 000B72 (2020) |
M L Solodky [France] ; C. Galvez [France] ; B. Russias [France] ; P. Detourbet [France] ; V. N'Guyen-Bonin [France] ; A-L Herr [France] ; P. Zrounba [France] ; J-Y Blay [France] | Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. |
| 000C97 (2020) |
Ilies Benotmane [France] ; Gabriela Gautier-Vargas [France] ; Marie-Josée Wendling [France] ; Peggy Perrin [France] ; Aurélie Velay [France] ; Xavier Bassand [France] ; Dimitri Bedo [France] ; Clément Baldacini [France] ; Mylène Sagnard [France] ; Dogan-Firat Bozman [France] ; Margaux Della-Chiesa [France] ; Morgane Solis [France] ; Floriane Gallais [France] ; Noëlle Cognard [France] ; Jérôme Olagne [France] ; Héloïse Delagrèverie [France] ; Louise Gontard [France] ; Baptiste Panaget [France] ; David Marx [France] ; Françoise Heibel [France] ; Laura Braun-Parvez [France] ; Bruno Moulin [France] ; Sophie Caillard [France] ; Samira Fafi-Kremer [France] | In-depth virological assessment of kidney transplant recipients with COVID-19. |
| 000D43 (2020) |
Doryaneh Ahmadpour ; Pedram Ahmadpoor [France] ; Lionel Rostaing | Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic. |
| 000E02 (2020) |
Antonella Marino Gammazza [Italie] ; Sébastien Légaré [France] ; Giosuè Lo Bosco [Italie] ; Alberto Fucarino [Italie] ; Francesca Angileri [France] ; Everly Conway De Macario [États-Unis] ; Alberto Jl Macario [États-Unis, Italie] ; Francesco Cappello [Italie] | Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. |
| 000E35 (2020) |
Emile Ferrari ; Benjamin Sartre ; Fabien Squara ; Julie Contenti ; Celine Occelli ; Fabien Lemoel ; Jacques Levraut ; Denis Doyen ; Jean Dellamonica ; Veronique Mondain ; David Chirio ; Karine Risso ; Eric Cua ; Jean Christophe Orban ; Carole Ichai ; Mohamed Labbaoui ; Baptiste Mossaz ; Pamela Moceri ; Anny Appert-Flory ; Florence Fischer ; Pierre Toulon | High prevalence of acquired thrombophilia without prognosis value in Covid-19 patients. |
| 000E39 (2020) |
Narjis Boukli [France] ; Melchior Le Mene [France] ; Aurélie Schnuriger [France] ; Nancy Stella Cuervo [France] ; Cécilia Laroche [France] ; Laurence Morand-Joubert [France] ; Joël Gozlan [France] | High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS-CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies. |
| 000E41 (2020) |
M. Pineton De Chambrun [France] ; C. Frere [France] ; M. Miyara [France] ; Z. Amoura [France] ; I. Martin-Toutain [France] ; A. Mathian [France] ; G. Hekimian [France] ; A. Combes [France] | High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? |
| 000E74 (2020) |
Antonino Uncini [Italie] ; Jean-Michel Vallat [France] ; Bart C. Jacobs [Pays-Bas] | Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. |
| 000F08 (2020) |
Intikhab Alam [Arabie saoudite] ; Allan A. Kamau [Arabie saoudite] ; Maxat Kulmanov [Arabie saoudite] ; Łukasz Jaremko [Arabie saoudite] ; Stefan T. Arold [Arabie saoudite, France] ; Arnab Pain [Arabie saoudite, Japon] ; Takashi Gojobori [Arabie saoudite] ; Carlos M. Duarte [Arabie saoudite] | Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2. |
